Cagri Doǧan

Dr. Cagri Doǧan


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

8 September 2026 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
CDCagri Doǧan
Cagri Doǧan
AGAlper Gezdirici
Alper Gezdirici
HÖHatice Özışık
Hatice Özışık
SÖSamim Özen
Samim Özen
AAAyça Aykut
Ayça Aykut
MMMehmet Burak Mutlu
Mehmet Burak Mutlu

21 October 2026 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
CDCagri Doǧan
Cagri Doǧan
MMMehmet Burak Mutlu
Mehmet Burak Mutlu
ACAli Cansu
Ali Cansu
EHEsra Habiloğlu
Esra Habiloğlu
MÖMurat Öztürk
Murat Öztürk
IKIrem Kalay
Irem Kalay
Background: In males, MECP2 loss of function was long thought to be lethal or uniformly severe, and affected boys remain under-recognised. Their clinical range is still poorly defined. Methods: We assembled a multicentre Turkish series of 22 hemizygous male probands ascertained through routine diagnostic testing rather than severe-phenotype registries. Variants were classified under the ClinGen Expert Panel specification for MECP2 (GN036, version 6.0.0) and its combining rules, with the Panel’s ClinVar classifications adopted where available. Phenotypic analysis was restricted to the 21 probands with pathogenic, likely pathogenic or uncertain variants. Results: The 22 probands carried 17 distinct variants (11 missense, 5 frameshift and one 3’ untranslated region deletion), of which 2 were classified as pathogenic, 1 likely pathogenic, 13 uncertain and 1 benign (3, 4, 14 and 1 probands, respectively). Where recorded, intellectual disability or developmental delay affected 7 of 7 probands with pathogenic or likely pathogenic variants and 8 of 10 with uncertain variants; seizures affected 2 of 3 and 8 of 10, respectively. Growth or head-circumference findings, recorded in 9 of 21 probands, included obesity or overgrowth (5), microcephaly (4, one borderline) and short stature (3). A maternal carrier was identified in 6 of 22 families (five laboratory-confirmed); the other 16 mothers were untested, so no de novo event was confirmed. Second-locus findings, reported by referring laboratories in 3 probands, could not be independently reclassified. Conclusions: In this diagnostically ascertained series, phenotypes observed among males carrying MECP2 variants were graded rather than uniformly severe. Fourteen of the 21 probands carry variants of uncertain significance, in whom causation is not established, so the range that may be attributed to MECP2 rests on seven individuals carrying variants classified as pathogenic or likely pathogenic under the stated criteria. In one of them, published functional data on the identical variant conflict with its pathogenic classification, so attribution of his phenotype to MECP2 remains uncertain. These provisional observations support a low threshold for MECP2 testing in males with unexplained neurodevelopmental presentations, attention to growth as well as head circumference, and consideration of additional loci.

1 January 2026 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
MSMert Sakar
Mert Sakar
CDCagri Doǧan
Cagri Doǧan
Necdet ApaydinNecdet Apaydin
Necdet Apaydin
Gokhan IpekogluGokhan Ipekoglu
Gokhan Ipekoglu
This study investigated the effect of the MC4R rs17782313 ( T > C) polymorphism on substrate oxidation and metabolic responses during exercise in healthy sedentary men. Forty-eight participants (aged 20–30 years) underwent genotyping and completed a graded exercise test with respiratory gas analysis to assess oxygen consumption (VO 2 ), respiratory quotient (RQ), and fat and carbohydrate oxidation rates. Participants were grouped as C-allele carriers (risk allele) and TT homozygotes. Group comparisons were conducted for VO 2 , RQ, substrate oxidation rates, and body mass index (BMI). Statistical analysis revealed no significant differences between genotypes in RQ, fat oxidation percentage, or carbohydrate oxidation percentage during moderate-intensity exercise ( p > 0.05). However, significant differences were observed in BMI, with C-allele carriers exhibiting higher BMI values compared to TT homozygotes ( p < 0.05). These results indicate that while the MC4R rs17782313 variant is associated with increased adiposity, it does not appear to affect acute substrate utilization during exercise. Thus, its contribution to obesity risk may be primarily mediated by behavioral and neuroendocrine mechanisms influencing energy intake rather than impairments in metabolic flexibility.

1 October 2025 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Verified
Journal Article
Open access
CDCagri Doǧan
Cagri Doǧan
EDElif Doğan
Elif Doğan
The present study aims to elucidate the genetic and molecular complexity of a family with previously diagnosed phenylketonuria (PKU), emphasising the importance of genetic screening and diagnostic testing in the management of inherited metabolic disorders. Following the initial biochemical diagnosis via newborn screening, a four-membered family (mother and three daughters from two different marriages) underwent molecular genetic testing. The DNA was extracted, and a Next Generation Sequencing (NGS) procedure was performed to analyse mutations in the phenylalanine hydroxylase (PAH) gene. Three daughters were the subjects of the evaluation: two were diagnosed with PKU and one was identified as a carrier. All affected individuals were compound heterozygotes with pathogenic variants in the PAH gene. The identified mutations were PAH (NM_000277.3): c.1208C>T (p.A403V), PAH (NM_000277.3): c.1243G>A (p.D415N) and PAH (NM_000277.3): c.688G>A (p.V230I), all previously reported in literature as pathogenic with mild to moderate phenotypic effects. One daughter exhibited normal development and was a heterozygous carrier. Despite delayed dietary compliance in the affected individuals, neurodevelopmental impairments were moderate, likely reflecting the genotype-phenotype correlations.Inherited metabolic diseases like PKU impose significant but preventable burdens on individuals and health systems. Pre-marital genetic counselling and targeted carrier screening, especially in populations with high consanguinity rates, are vital tools for prevention. Strengthening public awareness and genetic literacy can help cultivate a healthier generation through informed reproductive choices.

31 March 2026 in Gazi Medical Journal
Verified
Journal Article
Open access
PDF file
CDCagri Doǧan
Cagri Doǧan
AGAslı Odabaşı Giden
Aslı Odabaşı Giden
MÖMuhammet Özbilen
Muhammet Özbilen
Investigation of HFE Mutations Associated with Hemochromatosis the Case of Ordu Province - Gazi Medical Journal